Chefaa, an Egyptian health technology startup, has secured a $5.25 million investment in a funding round co-led by Newtown Partners and Global Brain. Notable investors include GMS Capital Partners LLC (US), Verod-Kepple Africa Ventures (Nigeria), and M3, Inc. (Japan). Founded in 2017 by Rasha Rady and Doaa Aref, Chefaa operates as a female-led e-pharmacy platform, offering end-to-end healthcare services. The funding will drive the expansion of Chefaa's operations, with a focus on strengthening its presence in Saudi Arabia, where it recently launched services in eight cities. The startup's comprehensive approach includes medication delivery, online doctor consultations, and tools for managing chronic diseases.
Chefaa's ambitious plans involve scaling operations across various Saudi cities, developing models for digitizing the healthcare supply chain, and investing in platform and service enhancements. The funding reflects investor confidence in Chefaa's success, innovation, and commitment to improving healthcare accessibility. This milestone reinforces Chefaa's dedication to positive impact and marks a significant stride in transforming healthcare delivery in the region.